General Information of This Antibody-drug Conjugate (ID: DRG0TZVTS)
ADC Name
SYS6040
Synonyms
SYS6040
   Click to Show/Hide
Organization
CSPC Pharmaceutical Group (Originator)
Drug Status
Phase 1
Antibody Name
Anti-DLL3 antibody
 Antibody Info 
Antigen Name
Delta-like protein 3 (DLL3)
 Antigen Info 
Payload Name
Undisclosed
Payload Target
Undisclosed
Linker Name
A cleavable linker
 Linker Info 
Conjugate Type
Undisclosed
2027 Update
The disease landscape of This ADC
2027 Update
The clinical trial pipelines of This ADC
Disease Name Phase 1 Phase 2 Phase 3 Approved
Lung cancer
1 Trials
Clinical trial identifier
pmct00000330; NCT06970795; CTR20251256
Unspecific solid tumor
1 Trials
Clinical trial identifier
pmct00000330; NCT06970795; CTR20251256